IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients
3rd October 2024 Uncategorised 0
Phase 1 trial of IRL757 demonstrates good absorption and safety profile

More: IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients
Source: News
